Skandinaviska Enskilda Banken AB (publ) - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$709
-16.9%
17,526
-4.4%
0.01%
-16.7%
Q4 2022$853
-99.9%
18,338
-5.5%
0.01%
-25.0%
Q3 2022$1,006,000
+9.7%
19,4000.0%0.01%
+14.3%
Q2 2022$917,000
-33.6%
19,4000.0%0.01%
-12.5%
Q1 2022$1,381,000
+31.0%
19,400
+37.2%
0.01%
+60.0%
Q4 2021$1,054,000
+123.3%
14,141
+50.4%
0.01%
+25.0%
Q2 2020$472,000
-85.3%
9,400
-85.0%
0.00%
-76.5%
Q1 2020$3,220,000
+57.0%
62,600
+88.6%
0.02%
+6.2%
Q4 2019$2,051,000
+18.1%
33,200
+14.9%
0.02%
+6.7%
Q3 2019$1,736,000
-14.3%
28,900
+20.4%
0.02%
-11.8%
Q2 2019$2,025,000
-29.1%
24,000
-19.7%
0.02%
-34.6%
Q1 2019$2,856,000
+16.9%
29,900
-13.3%
0.03%
+18.2%
Q4 2018$2,444,000
+63.3%
34,500
-49.2%
0.02%
+29.4%
Q2 2016$1,497,000
-67.4%
67,900
-56.6%
0.02%
-67.3%
Q1 2016$4,593,000
-28.6%
156,400
-18.8%
0.05%
-37.3%
Q4 2015$6,437,000192,5000.08%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,546,097$66,590,0009.91%
RA Capital Management 1,539,586$66,310,0006.70%
SENZAR ASSET MANAGEMENT, LLC 255,128$10,988,0004.20%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 158,315$6,819,0001.56%
Sarissa Capital Management LP 105,000$4,522,0001.54%
Ghost Tree Capital, LLC 50,000$2,154,0001.52%
BENNETT LAWRENCE MANAGEMENT L L C/NY 118,445$5,102,0000.90%
WALL STREET ASSOCIATES 219,200$9,441,0000.81%
Granite Point Capital Management, L.P. 25,000$1,077,0000.74%
BAILARD, INC. 91,500$3,941,0000.61%
View complete list of ENANTA PHARMACEUTICALS INC shareholders